F16.959 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified

Name of the Condition

• Hallucinogen Use, Unspecified with Hallucinogen-Induced Psychotic Disorder, Unspecified
• Medical Term: ICD-10-CM F16.959

Summary

Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified refers to the use of hallucinogenic substances associated with the development of a psychotic disorder without further specification of the psychotic features. This code is applied when clinical documentation confirms hallucinogen exposure and the presence of a psychotic disorder, but the specific symptoms (e.g., delusions, hallucinations) are not detailed. It encompasses cases where hallucinogen use is linked to psychotic symptoms, with the documentation not specifying the nature of the psychotic presentation or the pattern of use.

Causes

Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. The psychotic disorder arises from the direct effects of the hallucinogen on the central nervous system, leading to transient or persistent psychotic symptoms. The documentation does not specify a problematic pattern beyond the association with the induced psychotic disorder.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions (e.g., schizophrenia, bipolar disorder)
• Genetic predisposition to psychotic disorders
• High-dose or frequent hallucinogen use

Symptoms

• Altered perception, mood, or cognitive function
• Psychotic symptoms (e.g., delusions, hallucinations, disorganized thinking)
• Impaired judgment or reality testing
• Emotional dysregulation (e.g., anxiety, paranoia)

Diagnosis

Diagnosis requires clinical documentation confirming hallucinogen exposure and the presence of a psychotic disorder. The provider must rule out other causes of psychosis (e.g., primary psychiatric disorders, substance intoxication/withdrawal from other substances). Assessment may include psychiatric evaluation, substance use history, and collateral information to establish the temporal relationship between hallucinogen use and psychotic symptoms.

Treatment Options

• Discontinuation of hallucinogen use
• Antipsychotic medications to manage psychotic symptoms
• Psychotherapy (e.g., cognitive-behavioral therapy) to address substance use and psychotic symptoms
• Supportive care (e.g., monitoring, crisis intervention)
• Referral to addiction or psychiatric specialists as needed

Prognosis and Follow-Up

Prognosis depends on the severity of the psychotic disorder, duration of hallucinogen use, and response to treatment. Some individuals may experience resolution of symptoms with abstinence, while others may have persistent or recurrent psychosis. Follow-up includes monitoring for relapse, ongoing substance use, and adjustment of treatment (e.g., medication, therapy) to address residual symptoms or comorbidities.

Complications

• Persistent or chronic psychotic disorder
• Worsening of pre-existing mental health conditions
• Impaired social or occupational functioning
• Increased risk of accidental injury or self-harm
• Substance use disorder progression

Lifestyle & Prevention

• Avoidance of hallucinogenic substances
• Education on the risks of hallucinogen use
• Stress management techniques to reduce triggers
• Support from family, friends, or peer groups
• Engagement in healthy activities (e.g., exercise, hobbies) to promote well-being

When to Seek Professional Help

Seek immediate medical attention if experiencing severe psychotic symptoms (e.g., delusions, hallucinations, suicidal thoughts) or if hallucinogen use is interfering with daily life. Contact a healthcare provider for persistent or worsening symptoms, or if substance use is difficult to control.

Tips for Medical Coders

• Confirm clinical documentation supports both hallucinogen use and a hallucinogen-induced psychotic disorder.
• Ensure the code is used when psychotic symptoms are present but not further specified (e.g., no mention of delusions or hallucinations).
• Verify the code is not applied if the psychotic disorder is due to another cause (e.g., primary psychiatric condition, other substance use).
• Document the temporal relationship between hallucinogen use and psychotic symptoms to justify the diagnosis.